Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodies is a research paper published in npj Vaccines (2021). On theSindex it has a DataRank of 0.385. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.385
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →University of Texas Medical Branch
Grant: CoVID19 Grant
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Grant: AI145666
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Grant: AI147903
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Grant: AI120942
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Grant: AI134907
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Grant: AI127744
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Grant: AI140569-01A1W1
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences
Grant: UL1TR001439
NIAID NIH HHS
Grant: R56 AI145666
NIAID NIH HHS
Grant: R01 AI127744
NIAID NIH HHS
Grant: R21 AI147903
NIAID NIH HHS
Grant: R21 AI140569
NIAID NIH HHS
Grant: R01 AI134907
NIAID NIH HHS
Grant: R24 AI120942
National Institutes of Health
Grant: 5R24AI120942-05
World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)
National Institutes of Health
Grant: 5R01AI127744-05
Revolutionary Eilat-based Chikungunya Vaccine Vector
National Institutes of Health
Grant: 1R21AI147903-01A1
In vitro and in vivo analysis of susceptibility of Ad26 vector-induced CD4 T cells to HIV/SIV
National Institutes of Health
Grant: 3R01AI134907-03S2
A High-Throughput Platform for COVID-19 Serodiagnosis, Vaccine Evaluation, and Drug Discovery
National Institutes of Health
Grant: 5R21AI140569-02
Pellino-1, a novel target for treatment of congenital Zika syndrome
National Institutes of Health
Grant: 1R56AI145666-01
Modulation of BRD4 to epigenetically suppress HIV
National Institutes of Health
Grant: 5UL1TR001439-07
UTMB Clinical and Translational Science Award
Sealy & Smith Foundation, Kleberg Foundation, the John S. Dunn Foundation, the Amon G. Carter Foundation, the Gilson Longenbaugh Foundation, and the Summerfield Robert Foundation.
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
FWCI
0.75
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals